In 2 new education documents, Physicians for Informed Consent outlines the risks of Hepatitis B compared to the risks of the Hepatitis B vaccination.
Physicians for Informed Consent (PIC) has recently released 2 education documents. The first is a Disease Information Statement for hepatitis B titled, “Hepatitis B: What Parents Need to Know,” and the second is a Vaccine Risk Statement for Hepatitis B titled, “Hepatitis B Vaccine: Is It Safer Than Hepatitis B?”
These documents were developed to help people assess the risks of hepatitis B and its vaccine and make an informed decision on vaccination.
“New parents need to know that if their infants are normal-risk, which 99% of newborns are, then the chance of them getting fatal hepatitis B is 0.00001% or one in seven million — a prevaccine statistic,” said Shira Miller, MD, PIC founder and president. “They also need to know that all hepatitis B vaccines include the neurotoxin aluminum — which means there’s a 100% guarantee their infant will be exposed to aluminum if they get injected with a hepatitis B vaccine.”
The documents explain what Hepatitis B is, what the side effects of the hepatitis B vaccine are, and whether the vaccine is safer than Hepatitis B. Important information is discussed, such as how an unvaccinated normal-risk children has a 1 in 7 million chance of developing fatal hepatitis B.
Another fact included in the documents is that about 50% of children vaccinated for hepatitis B lose their immunity before age 5. The vaccine also does not have a significant effect on the appearance of chronic hepatitis B infection, and it may cause seizures in about 1 in 1300 children. The level of aluminum in the vaccine is about 75 times greater than the maximum amount of aluminum safe for infants weighing about 7 pounds.
When analyzing the evidence, the Institution of Medicine concluded that the possibility of the hepatitis B vaccination causing more than 2 dozen neurological and autoimmune disorders cannot be ruled out.
Reference
Physicians for informed consent (PIC) releases new educational documents assessing risks of hepatitis b compared to risks of the hepatitis b vaccine. AP News. September 13, 2022. Accessed September 14, 2022. https://apnews.com/article/health-hepatitis-34b54ae18a98c003891df7b421f3425b
Study shows dengue vaccine is safe and effective
October 11th 2024Overall, 2 doses of TAK-003 successfully induced the production of neutralizing antibodies against all 4 dengue serotypes in at least 90% of adults, children, and adolescents, regardless of whether they were seronegative or seropositive at baseline.